City
Epaper

30 crore people to be vaccinated against COVID-19 in first phase: Max hospital Cardiologist

By ANI | Updated: January 3, 2021 06:10 IST

As the country is eagerly waiting for the COVID-19 vaccination programme to begin, Dr Manoj Kumar, senior cardiologist at Max Hospital, New Delhi said that in the first phase, almost 30 crore population will be covered.

Open in App

As the country is eagerly waiting for the COVID-19 vaccination programme to begin, Dr Manoj Kumar, senior cardiologist at Max Hospital, New Delhi said that in the first phase, almost 30 crore population will be covered.

"Recently, the Drugs Controller General of India (DCGI) has approved the Serum Institute of India (SII) vaccine Covishield. There is also the possibility that COVAXIN of Bharat Biotech will be approved. This is good news in New Year. In the initial phase, they have planned to vaccinate one crore healthcare workers and two crore frontline corona warriors. In the first phase of vaccination, they are planning to vaccinate almost 30 crore population" Dr Kumar told .

Dr Kumar said that vaccination is based on two things -essentiality and vulnerability.

"The healthcare workers and frontline corona warriors are a priority and are essential. But people having more than 65 years of age having co-morbidities, they are also important and vulnerable. So almost 30 crore doses are planned for the first phase of the vaccination," he added.

The Subject Expert Committee of CDSCO met on Friday and Saturday and recommended to grant the permission for restricted emergency use of the vaccine, subject to multiple regulatory conditionalities, to Serum Institute of India, Pune.

It also recommended the grant of permission for restricted use in an emergency situation in the public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains, to Bharat Biotech International Ltd Hyderabad.

The recommendations were made for the consideration and final decision of the Drugs Controller General of India.

Covaxin is an indigenously developed coronavirus vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Union Health Minister Dr Harsh Vardhan had on Saturday said that in the first phase of COVID-19 vaccination, free vaccine shall be provided across the nation to most prioritised beneficiaries that include one crore healthcare and two crore frontline workers.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

CricketAUS vs ENG: Australia Announce Playing XI for 1st Ashes 2025-26 Test; Jake Weatherald, Brendan Doggett to Make Debuts

CricketWTC Points Table: Updated ICC World Test Championship 2025-27 Standings Ahead of 1st Ashes Test and India vs South Africa 2nd Test

TechnologyMore than 1 billion 5G subscriptions expected in India by 2031: Report

EntertainmentEktaa Kapoor calls brother Tusshar Kapoor her ‘guide and support’ in a heartfelt birthday post

BusinessMore than 1 billion 5G subscriptions expected in India by 2031: Report

National Realted Stories

NationalBLO suffers cerebral attack in middle of SIR related work in Bengal's Hooghly district

NationalDharmasthala mass grave probe: SIT names activists as accused in 4,000-page charge sheet

NationalEternally grateful to PM Modi: Former Bangladesh PM Sheikh Hasina's son amid extradition call after death sentence

National'Wishing them success': VP Radhakrishnan congratulates Nitish Cabinet on taking oath

NationalEx-Andhra CM Jagan appears before CBI court in disproportionate assets case